Real World Evidence in COPD patients.
Not Applicable
- Conditions
- Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
- Registration Number
- CTRI/2023/08/056077
- Lead Sponsor
- Zydus Healthcare Ltd. India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Eligible for single inhaler triple therapy (LABA + LAMA + ICS) as per clinician’s discretion
Gives signed written informed consent to participate.
For Female patients
A female is eligible to enter and participate in the study if she is of non-childbearing potential (i.e., physiologically incapable of becoming pregnant, including any female who is 2 years post-menopausal)
For females with childbearing potential, who agrees for contraception throughout - from Visit 1 (Screening) till 1 month after the final visit)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method